Structural variant and nucleosome occupancy dynamics postchemotherapy in a HER2+breast cancer organoid model
成果类型:
Article
署名作者:
Starostecka, Maja; Jeong, Hyobin; Hasenfeld, Patrick; Garagorri, Eva Benito -; Christiansen, Tania; Brasseur, Catherine Stober; Queiroz, Maise Gomes; Montero, Marta Garcia; Jechlinger, Martin; Korbel, Jan O.
署名单位:
Bristol-Myers Squibb; European Molecular Biology Laboratory (EMBL); Yonsei University; Helmholtz Association; German Cancer Research Center (DKFZ); European Molecular Biology Laboratory (EMBL)
刊物名称:
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
ISSN/ISSBN:
0027-9918
DOI:
10.1073/pnas.2415475122
发表日期:
2025-03-04
关键词:
mutational processes
doxorubicin
signatures
EVOLUTION
SURVIVORS
network
cells
摘要:
The most common chemotherapeutics induce DNA damage to eradicate cancer cells, yet defective DNA repair can propagate mutations, instigating therapy resistance and secondary malignancies. Structural variants (SVs), arising from copy- number- imbalanced and - balanced DNA rearrangements, are a major driver of tumor evolution, yet understudied posttherapy. Here, we adapted single- cell with nucleosome occupancy (NO) measurements obtained from the same single cell to enable simultaneous SV detection and cell- type classification. Using organoids fying a 7.4- fold increase in large chromosomal alterations post- doxorubicin. Complex DNA rearrangements, deletions, and duplications were prevalent across basal, luminal nucleosome occupancy levels on distinct cancer- related genes further underscore the multiomics established in this study paves the way for unraveling the most important of therapy on cancer evolution.